In contrast, we show that methylstat alone had cytotoxic effects on both, PARPi-sensitive and PARPi-resistant ovarian cancer cells, while additionally potentiating the effect of olaparib among PARPi-resistant, PARPi-sensitive and BRCA1-proficient cell lines. This evidence concerns the gene BRCA1 and ovarian cancer.